⏳ Fetching live dividend data...
Home › Calculator › EPZM Dividend Calculator 2026
Epizyme, Inc. · NASDAQ
Price: $1.47 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in EPZM → $31.79M in 10 years · $3,515.44/month
Epizyme, Inc. is a biopharmaceutical enterprise that operates at a commercial level, dedicated to discovering, advancing, and bringing to market innovative epigenetic therapies for individuals battling cancer and other medical conditions across the United States. Its flagship commercial product is Tazemetostat, prescribed for the management of metastatic or locally advanced epithelioid sarcoma in both adult and pediatric populations. Beyond this, Epizyme is actively engaged in developing several other therapeutic candidates. These include R-CHOP for initial treatment in patients suffering from high-risk diffuse large B-cell lymphoma, and a PARP inhibitor targeting solid tumors that have become resistant to other PARP inhibitors, encompassing conditions like castration-resistant prostate cancer and small cell lung cancer. Furthermore, the company is exploring additional applications for Tazemetostat in treating INI1-negative tumors in both children and adults. Its pipeline also features a PRMT5 inhibitor intended for solid tumors and a PRMT1 inhibitor. Epizyme maintains strategic alliances and collaborative agreements with various partners, such as Roche Molecular Systems, Inc., the Lymphoma Academic Research Organization, Eisai Co. Ltd., HUTCHMED (China) Limited, and Roche Sequencing Solutions, Inc. Founded in 2007, the company's corporate headquarters are situated in Cambridge, Massachusetts. Since August 11, 2022, Epizyme, Inc. has operated as a wholly-owned subsidiary of Ipsen Biopharmaceuticals, Inc.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EPZM position with:
Real after-tax yield depends on where you live and how you hold EPZM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 136.05% | 133.25% | $13,605 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 115.64% | 112.84% | $11,564 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 108.84% | 106.04% | $10,884 / yr |
| 🇬🇧 UK ISA | 0% | 136.05% | 133.25% | $13,605 / yr |
| 🇬🇧 UK Taxable | 8.75% | 124.15% | 121.35% | $12,415 / yr |
| 🇨🇦 TFSA | 0% | 136.05% | 133.25% | $13,605 / yr |
| 🇨🇦 CA Taxable | 25% | 102.04% | 99.24% | $10,204 / yr |
| 🇦🇺 Super (pension) | 15% | 115.64% | 112.84% | $11,564 / yr |
| 🇦🇺 AU Taxable | 30% | 95.23% | 92.44% | $9,524 / yr |
| 🇩🇪 DE Taxable | 26.375% | 100.17% | 97.37% | $10,017 / yr |
| 🇫🇷 FR Taxable | 30% | 95.23% | 92.44% | $9,524 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
EPZM pays quarterly — 4 times per year. Next ex-div: TBD.
How EPZM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EPZM sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2022-08-12 | 8,994 | — | — | ||
| D-Return | 2022-08-12 | 13,060 | $1.45 | $18.9K | ||
| D-Return | 2022-08-12 | 3,380,951 | $1.45 | $4.90M | ||
| D-Return | 2022-08-12 | 8,994 | — | — | ||
| D-Return | 2022-08-12 | 53,324 | — | — | ||
| D-Return | 2022-08-12 | 8,994 | — | — | ||
| U-Tender | 2022-08-12 | 215,494 | $1.45 | $312.5K | ||
| U-Tender | 2022-08-12 | 215,494 | — | — | ||
| D-Return | 2022-08-12 | 8,994 | — | — | ||
| U-Tender | 2022-08-12 | 106,959 | $1.45 | $155.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EPZM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Epizyme, Inc. (EPZM) is currently trading at $1.47, 87% below its 52-week high. The current dividend yield is 136.05% based on an annual payout of $2.00 per share.
Epizyme, Inc. (EPZM) is a healthcare stock currently trading at $1.47 with a dividend yield of 136.05%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →